Talphera Inc. (NASDAQ: TLPH) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT TALPHERA INC.

Talphera Inc. (NASDAQ: TLPH)
Listen to this Section


$0.77
+0.0021 ( +0.27% ) 0.2K

Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

Clinical Trial Pipeline Stages


Drug Name Stage
DSUVIA (sufentanil)DetailsPost operative acute pain Approved
Nafamostat (Niyad™)DetailsMedical deviceBig Mover™Suspected Mover™Susp. Mover™ Phase 3
Zalviso US (sufentanil)DetailsPost operative acute pain Failed

Market Data


Open $0.77
Previous Close $0.77
Volume 0.2K
Market Cap $39.71M
Day Range $0.79 - $0.80
52 Week Range $0.38 - $1.57
Shares Outstanding 51.90M
Change % +0.27%
Net Change ▲ 0.0021
Insider Ownership 0.00%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2011
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -3,390,864.00

Date Type Amount Purchased Purchaser
2024-02-27 Sale -14667.00 Dasu Badri N
2024-02-13 Sale -809.00 Dasu Badri N
2024-02-13 Sale -801.00 Palmer Pamela P
2024-02-13 Sale -895.00 ASADORIAN RAFFI
2024-02-13 Sale -3320.00 Angotti Vincent J.
2024-01-24 Sale -2205883.00 Nantahala Capital Management, LLC
2024-01-23 Sale -871.00 JAIN ABHINAV
2023-12-14 Buy 10000.00 Angotti Vincent J.
2023-12-13 Sale -581.00 HOFFMAN STEPHEN J
2023-12-13 Sale -581.00 Rosen Howard B

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 61 Nov 12, 2025
8-k 8K-related 15 Nov 12, 2025
4 Insider transactions 1 Oct 24, 2025
8-k 8K-related 15 Oct 24, 2025
4 Insider transactions 1 Oct 24, 2025
4 Insider transactions 1 Oct 24, 2025
4 Insider transactions 1 Oct 24, 2025
4 Insider transactions 1 Oct 24, 2025
4 Insider transactions 1 Oct 24, 2025
8-k 8K-related 13 Oct 22, 2025

Latest News


× Before browsing our site, please accept our cookies policy